Allo-Hemodialysis: A Narrative Review of a Novel Approach to Resource-Sparing Kidney Replacement Therapy
Journal of Clinical Medicine · 08.11.2026 · 15 (21) · 8717
DOI: 10.3390/jcm15218717 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 08.11.2026. Verfasst von Peter Kotanko und 15 weiteren Autor:innen. Beteiligte Einrichtung: Renal Research Institute, New York, NY 10065, USA. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Renal Research Institute.
Abstract (Originalsprache)
Conventional hemodialysis (HD) is one of the most resource-intensive therapies in medicine and remains inaccessible to a large share of the world’s population with kidney failure. Allo-hemodialysis (alloHD) is a novel hemodialysis concept in which the blood of a healthy volunteer (“buddy”) replaces manufactured dialysate, flowing counter-currently to the patient’s blood across a conventional dialyzer membrane. Uremic solutes and excess fluid move from the patient into the buddy’s circulation and are cleared by the buddy’s own kidneys, while bicarbonate and water-soluble vitamins diffuse back to the patient. By eliminating water treatment, dialysate production, and much of a conventional machine’s electromechanical complexity, alloHD has the potential to lower the cost, complexity, and environmental footprint of kidney replacement therapy. This review synthesizes the evidence for alloHD, spanning two-compartment urea and acid–base kinetic modeling, ex vivo bench testing of a low-cost prototype, and in vivo porcine studies of acute kidney injury, while describing a modeling extension to severe neonatal jaundice. We summarize buddy safety considerations as well as review ethical issues and caregiver/health-care professional acceptance data. Finally, we position alloHD within the broader movement toward more sustainable and personalized dialysis, and outline the translational steps required before first-in-human study.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Renal Research Institute, New York, NY 10065, USA.
- Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Department of Pediatric Nephrology, Soba University Hospital, Khartoum 13314, Sudan.
- Fresenius Medical Care Deutschland GmbH, 97424 Schweinfurt, Germany.
- Department of Paediatrics, Western University, London, ON N6A 3K7, Canada.
- School of Medicine at Chapel Hill, The University of North Carolina, Chapel Hill, NC 25799, USA.
ORCID-Profile: Peter Kotanko, Xin Wang, Nadja Grobe, Rasha Hussein, Guido Filler, Maria Díaz-González de Ferris, Nicholas Steneck
Förderung
- Renal Research Institute
Zitieren
APA
Kotanko, P., Maheshwari, V., Wang, X., Grobe, N., Cherif, A., Tao, X., Hussein, R., Patel, A., Emmanuel Chao, J., Heide, A., Nikolic, D., Dong, J., Filler, G., Díaz-González de Ferris, M., Steneck, N., & Nayak, K. S. (2026). Allo-Hemodialysis: A Narrative Review of a Novel Approach to Resource-Sparing Kidney Replacement Therapy. Journal of Clinical Medicine, 15(21), 8717. https://doi.org/10.3390/jcm15218717
Vancouver
Kotanko P, Maheshwari V, Wang X, Grobe N, Cherif A, Tao X, et al. Allo-Hemodialysis: A Narrative Review of a Novel Approach to Resource-Sparing Kidney Replacement Therapy. Journal of Clinical Medicine. 2026;15(21):8717. doi:10.3390/jcm15218717
BibTeX
@article{Kotanko2026,
author = {Kotanko, Peter and Maheshwari, Vaibhav and Wang, Xin and Grobe, Nadja and Cherif, Alhaji and Tao, Xia and Hussein, Rasha and Patel, Amrish and Emmanuel Chao, Joshua and Heide, Alexander and Nikolic, Dejan and Dong, Jiaming and Filler, Guido and Díaz-González de Ferris, Maria and Steneck, Nicholas and Nayak, Karopadi Shivanand},
title = {Allo-Hemodialysis: A Narrative Review of a Novel Approach to Resource-Sparing Kidney Replacement Therapy},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {21},
pages = {8717},
doi = {10.3390/jcm15218717}
}
EUVIMED